APA (7th ed.) Citation

Yan, D., Zubair, A., Osborne, M., Rosado, R. P., Stone, J., Lehman, V., . . . Qu, W. (2024). CELLKINE CLINICAL TRIAL: FIRST REPORT FROM A PHASE I TRIAL OF ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN SUBJECTS WITH PAINFUL LUMBAR FACET JOINT ARTHROPATHY. Cytotherapy (Oxford, England), 26(6), e8-e9. https://doi.org/10.1016/j.jcyt.2024.04.025

Chicago Style (17th ed.) Citation

Yan, D., et al. "CELLKINE CLINICAL TRIAL: FIRST REPORT FROM A PHASE I TRIAL OF ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN SUBJECTS WITH PAINFUL LUMBAR FACET JOINT ARTHROPATHY." Cytotherapy (Oxford, England) 26, no. 6 (2024): e8-e9. https://doi.org/10.1016/j.jcyt.2024.04.025.

MLA (9th ed.) Citation

Yan, D., et al. "CELLKINE CLINICAL TRIAL: FIRST REPORT FROM A PHASE I TRIAL OF ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN SUBJECTS WITH PAINFUL LUMBAR FACET JOINT ARTHROPATHY." Cytotherapy (Oxford, England), vol. 26, no. 6, 2024, pp. e8-e9, https://doi.org/10.1016/j.jcyt.2024.04.025.